KVUE | tickerfilter.com

Fundamental analysis

63%

Profitability 72%

Dept financing 40%

Liquidity 28%

Performance 69%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.68%

1 Month

1.22%

3 Months

-6.58%

6 Months

4.17%

1 Year

-26.16%

2 Year

-14.19%

Key data

Stock price

$17.47

P/E Ratio

20.70

DAY RANGE

$17.13 - $17.51

EPS

$0.80

52 WEEK RANGE

$14.02 - $24.36

52 WEEK CHANGE

-$24.70

MARKET CAP

33.581 B

YIELD

4.72%

SHARES OUTSTANDING

1.920 B

DIVIDEND

$0.2075

EX-DIVIDEND DATE

05-13-2026

NEXT EARNINGS DATE

08-05-2025

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$22,014,081

AVERAGE 30 VOLUME

$17,671,206

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc